en's Hospital ethics committee, and informed consent follows that of Anderson et al. (1981) . The nt 8993 (TrG) substitution introduces a novel HpaII restriction was obtained from all patients in this study. Control oocytes were donated by patients undergoing in vitro site at nt 8993, which is identified after digestion of the PCR product described above. PCR amplifications were fertilization at the Royal Women's Hospital.
Ovarian stimulation regimens have been reported performed for 35 cycles of 95ЊC for 1 min, 56ЊC for 1 min, and 72ЊC for 2 min. Ten-microliter aliquots of the elsewhere (Gook et al. 1994) . Oocyte maturation was triggered by an injection of human chorionic gonadotro-PCR reactions were digested in a total reaction volume of 20 ml containing 20 units of restriction endonuclease phin (HCG; 10,000 IU; Profasi; Serono) administered when three follicles ú18 mm were detected on ultra-HpaII, at 37ЊC for 3 h. The samples were electrophoresed through a 3.0% [w/v] NuSieve agarose gel consound. Eight oocyte-cumulus complexes were retrieved transvaginally under ultrasound guidance 36 h after taining ethidium bromide. PCR products were visualized by use of a 320-nm UV transilluminator. HCG administration. Oocyte-cumulus complexes were transferred to Earles balanced salt solution supple-3. PCR from Guthrie blood spots.-To each of the eluted samples was added 10 ml of 2 mM dNTPs, 1 ml mented with synthetic serum replacement, pyruvate, and 1% (w/v) human serum albumin (Medicult). At no time of primer 8961F (1 mg/ml stock), 1 ml of primer 9050R
(1 mg/ml stock), and 0.5 ml of Taq polymerase (5 were these oocytes exposed to sperm.
Individual oocytes were prepared, frozen, and thawed U/ml). PCR amplifications were performed for 35 cycles of 95ЊC for 1 min, 56ЊC for 1 min, and 72ЊC for 2 min). as described elsewhere (Gook et al. 1993) . Complete removal of cumulus and corona cells from the oocytes HpaII restriction digests were performed as described above. was achieved by brief exposure to hyaluronidase (50 IU/ml), followed by mechanical disruption. The zona 4. Radioactive (quantitative) PCR.-Either Ç20 ng of total DNA or 2 ml of the first-round whole-genome ampellucida was partially or completely removed by digestion with 0.125% (w/v) pronase (Boehringer Mannplification of the oocytes was amplified in a standard 50-ml PCR with the mtDNA primer set 8961F and heim) in 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid-buffered human tubular fluid medium 9050R. After 24 cycles of 95ЊC for 1 min, 56ЊC for 1 min, and 72ЊC for 2 min, 10 mCi of a 32 P-dCTP was (Irvine) supplemented with 20% (v/v) serum substitute (Irvine).
added to each sample during the denaturation step of the final cycle: 95ЊC for 3 min, 56ЊC for 1 min, and DNA Extraction 72ЊC for 2 min. Endonuclease HpaII digestion was as described Total DNA was extracted from whole blood, cultured skin fibroblasts, tissue samples, and Guthrie blood spots, above. The products were analyzed after electrophoresis through a 15% nondenaturing polyacrylamide gel. as described elsewhere (Blok et al. 1995b ).
The dried gel was exposed to x-ray film at room tem-PCR Studies perature, and the relative proportions of wild-type and mutant DNA were estimated after densitometry of the 1. Total genome amplification.-Pronase-treated oocytes (or 1 drop of pronase solution) were placed into autoradiogram by use of a Bio-Rad imaging densitometer (model GS-670). 20 ml of sterile distilled water and stored at 020ЊC until required. Prior to PCR analysis, the samples were incuTo confirm complete HpaII digestion, the primer set 3130F (5 3130-3149 3) and 3558R (5 3558-3539 bated at 95ЊC for 15 min to lyse the oocytes. Total genome amplification was performed in a total volume 3) was included in the PCR described above. This primer set amplifies the region of the mitochondrial geof 50 ml, as described elsewhere (Schmitt et al. 1994) , by use of a thermal cycler (model FTS-320; Corbett Re-nome either side of the HpaII restriction site at nt 3246.
Multiplex PCR products were digested with HpaII and search), with conditions of 95ЊC for 3 min; 49 cycles of 95ЊC for 1 min, 37ЊC for 2 min, and 55ЊC for 4 min; were analyzed as described above.
To determine the reproducibility of mtDNA mutantand 1 cycle of 95ЊC for 1 min, 37ЊC for 2 min, and 72ЊC for 7 min.
load estimations from single oocytes, we performed PCR analysis on four samples of patient DNA (isolated from 2. Gene-specific PCR.-Either 2 ml of the first-round PCR described above or 20 ng of total DNA extracted blood), with different loads of the nt 8993 (TrG) mutation. The mutant load was determined by six indepenfrom patient or control samples was used in a total reaction volume of 50 ml, for mtDNA gene-specific am-dent whole-genome amplifications of 350, 35, 3.5, and 0.35 pg of lymphocyte DNA of each sample, followed plification. Reactions were as described above, except that, in place of the random 15mer primers, the mtDNA-by radioactive gene-specific PCR analysis as described above. However, the number of PCR cycles was inspecific primer set used was 8961F (5 8961-8980 3) and 9050R (5 9050-9031 3), each at a concentration creased to 32, and the intensity of radioactive mutant and wild-type HpaII bands was determined on a Molecof 10 mg/ml. Mutation in Oocytes was sequenced as described elsewhere (Blok et al. 1995a ). The mtDNA D-loop region was amplified by After genetic counseling, III-1 decided to have a tubal ligation to prevent any subsequent pregnancies. At her use of primer set 15981F (5 15981-16000 3) and 57R (5 57-38 3) and primer set 16541F (5 16541-16560 request, and after informed consent was obtained, her ovaries were hyperstimulated, and eight oocytes were 3) and 630R (5 630-611 3). The DNAs were sequenced by use of the same primers plus primer set 420R harvested for analysis of the mtDNA mutation. Seven of the eight oocytes gave a result when analyzed for the (5 420-401 3) and 16400F (5 16400 load of the nt 8993 (TrG) mutation may have contained 1996]), a third male sibling who died at 3 mo of age the mutation at a level below the sensitivity of detection with a diagnosis of sudden infant death syndrome (SIDS) in our study. Control oocytes from an unrelated female (IV-2; fig. 1 ), and the asymptomatic mother (III-1; fig. were also negative for the mutation. Aliquots of first-1). The mother has a mutant load of 50% in her blood, round no-DNA negative controls were included in the consistent with both her being a carrier of the pathosecond-round mtDNA-specific PCR. These and secondgenic mtDNA point mutation and her lack of symptoms. round negative (no DNA) controls did not yield a PCR Generally, expression of the nt 8993 (TrG) mutation product, suggesting the absence of contaminating at a level ú70% is required for clinical symptoms (San-mtDNA in the reactions ( fig. 2 , lanes pri-1 and pri-2). torelli et al. 1993; Shoffner and Wallace 1995). In conTo confirm that the low levels of wild-type mtDNA trast, the three progeny of this woman had levels ú85% that we consistently observed in oocytes containing the in tissues analyzed. The mutation was not detected in mutation were not artifacts due to incomplete digestion, blood from other maternal relatives, when such was multiplex PCRs were performed, in which the secondround PCR described above included primers for amplification of a nonrelated mtDNA gene product with a single homoplasmic HpaII site. The control HpaII site was cleaved to completion under conditions in which the mtDNA in the oocytes was not (data not shown). Sequence analysis of the mtDNA nt 8993 region in oocyte 1 showed a wild-type sequence, making it unlikely that the absence of a HpaII site is due to a second mutation introduced during PCR amplification.
To ensure that there was not preferential amplification of one of the mtDNA variants, an aliquot of firstround whole genome-amplification PCR, from oocyte 1, was mixed with that of mutation-containing oocytes prior to the mtDNA-specific PCR. The presence of both mtDNA variants in the second-round PCR did not influence the efficiency of amplification of both sequence variants ( fig. 3) . We also performed whole-genome and We sequenced the mtDNA D-loop region (a 1,119-bp fragment spanning nt 16031-580) of maternal blood and oocyte 1 and confirmed, on the basis of the identity of the DNA sequences, that the DNA in oocyte 1 was maternally derived and not due to external contamination. Both sequences differed from that reported by Anderson et al. (1981) , at nt 263 (TrG) and at nt 303-309 (eight C's) and 311-315 (six C's). This D-loop sequence was not among 52 D-loop groups determined in 525 individuals, including 142 Caucasians (Stoneking et al. 1991) . On the basis of the frequencies of D-loop variations, the sequence in the mother and the oocyte should be found in õ3% of Caucasians, making it unlikely that the result from oocyte 1 is caused by contamination by ''foreign'' mtDNA.
To further exclude maternal or other contamination, X-chromosome short-tandem-repeat mapping was performed on the intron 45 short tandem (CA) n repeat of the X chromosome-encoded Duchenne muscular dystrophy gene (Clemens et al. 1991) . Both analysis of relevant family members and aliquots of the first-round whole-genome amplification PCR of selected mutation-
Figure 2
Oocytes displaying skewed levels of wild-type and mutant mtDNA. Whole-genome amplification of total DNA of lysed eggs from individual III-1 (lanes 1-8), control oocytes (unrelated oocytes 1 and 2), and negative PCR controls was performed simultaneously in a volume of 50 ml. mtDNA gene-specific amplification and quantitation of the nt 8993 (TrG) mutation utilized 1/25th of the wholegenome PCR in a standard second-round PCR with the mtDNA-specific primer set 8961F and 9050R, followed by HpaII digestion. The nt 8993 (TrG) mutation introduces a HpaII restriction site, so the expected digestion products are 89 bp (wild-type and uncut mtDNA) or 57 and 32 bp (nt 8993 [TrG] mutation present). The percentage of mutant mtDNA also is indicated. Lanes P-Bl, pri-1, and pri-2 show results in negative controls: P-Bl Å pronase solution amplified in the presence of primers in both rounds of PCR; pri-1 Å no-DNA/primersonly sample amplified in both rounds of PCR; and pri-2 Å secondround mtDNA-specific PCR no-DNA/primers-only sample. lent to that of a human oocyte. The four DNA samples (A-D) contained 0%, 19%, 30%, and 89% mutant mtDNA, as determined by direct gene-specific PCR analysis of 20 ng of DNA. Six independent whole-genome amplifications of 350, 35, 3.5, and 0.35 pg of DNA of Figure 3 mtDNA amplification shown to be not variant specific.
each sample, followed by radioactive gene-specific PCR Aliquots (2 ml total) of the first-round whole-genome amplification of analysis, gave consistent and reproducible results, simi-indicated oocytes were mixed and amplified in a second-round lar to those obtained by the direct analysis of 20 ng of mtDNA gene-specific PCR with the primer set 8961F and 9050R. After radioactive PCR, 10-ml aliquots of the PCR reaction were di-DNA (table 1) . The most-dilute samples gave the weakgested with HpaII. Undigested (A) and digested (B) products were est signals and, consequently, the poorest signal-to-noise electrophoresed through a 15% nondenaturing polyacrylamide gel. HpaII digestion products are as described in the legend to figure 2.
Thus, preferential amplification of a single mtDNA spe-/ 9a2a$$ju02 05-23-97 17:31:14 ajhga UC-AJHG is an accumulation of mtDNA deletions and point muta- actively removed in oocytes, or were only rarely transmitted through the mitochondrial bottleneck. Recently, Jenuth et al. (1996) have created a heteroplasmic mouse containing oocytes and of the nonmutant oocyte of III-model that enabled them to study mtDNA distribution 1 were consistent with the origin of the oocytes. Each in mature and progenitor oocytes. It was concluded that oocyte tested had only one of the mother's X-chromorandom segregation and a bottleneck of Ç200 mtDNA some alleles, indicating that there was no contamination in mouse progenitor oocytes could explain the distribuof the oocyte mtDNA by maternal or other DNA (data tion of two polymorphic mtDNAs in heteroplasmic not shown).
mice. It is difficult to envisage how such a model could explain our results and the rapid changes in nt 8993 Discussion (TrG) mutation load between generations in some human pedigrees (Tulinius et al. 1995; de Coo et al. 1996 ). It has not previously been possible to measure levels of an mtDNA variant in human oocytes. The frequencies Mice may segregate mtDNA variants less rapidly than humans do. of mtDNA variants in human tissues therefore have been determined in somatic tissues in which the variant DNA Two factors seem most relevant to the heritability of mtDNA mutations. First, if a mutation is present in only has been subjected to postfertilization segregation events and, possibly, tissue-specific selection. When the for-a small proportion of genomes in the primordial oocyte, as would be the case with age-associated mutations, then mula used to calculate mtDNA numbers at the bottleneck (Ashley et al. 1989; Howell et al. 1992 ) is applied preferential transmission of a single genome usually will prevent transfer to the primary oocyte. Second, there to the blood mutant loads in our family, it yields an estimate of 800-4,000, whereas the data from the oois the functional consequence of a particular mtDNA mutation. Studies, at the cellular level, of pathogenic cytes and from the mother's blood predicts a range of 15-70. The exact number of mitochondrial genomes at mtDNA point mutations suggest that these usually need to be expressed at a level ú95% in order to show a the time of the bottleneck is unclear. However, during maturation from the primordial oocyte to the mature biochemical defect (Chomyn et al. 1992; King et al. 1992; Trounce et al. 1994; Shoffner and Wallace 1995) . oocyte, which contains Ç100,000 mtDNA, the number of mitochondrial genomes increases by §50-fold, and These point mutations are unlikely to compromise en- dria being the units of segregation.
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The data obtained in our study have implications for 
